BioPharma Credit (LSE:BPCR) Scaled Net Operating Assets : 0.88 (As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BioPharma Credit's operating assets for the quarter that ended in Dec. 2022 was $1,243.5 Mil. BioPharma Credit's operating liabilities for the quarter that ended in Dec. 2022 was $26.6 Mil. BioPharma Credit's Total Assets for the quarter that ended in Jun. 2022 was $1,388.2 Mil. Therefore, BioPharma Credit's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2022 was 0.88.

BioPharma Credit Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BioPharma Credit's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(1270.53	-	15.871)	/	1364.016
=	0.92

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Balance Sheet Cash And Cash Equivalents
=	1356.732	-	86.202
=	1270.53

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	15.871	-	0	-	0
=	15.871

BioPharma Credit's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2022 )
=	(Operating Assets (Q: Dec. 2022 )	-	Operating Liabilities (Q: Dec. 2022 ))	/	Total Assets (Q: Jun. 2022 )
=	(1243.489	-	26.563)	/	1388.209
=	0.88

where

	Operating Assets		(Q: Dec. 2022 )
=	Total Assets	-	Balance Sheet Cash And Cash Equivalents
=	1364.016	-	120.527
=	1243.489

	Operating Liabilities		(Q: Dec. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	26.563	-	0	-	0
=	26.563

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioPharma Credit Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

BioPharma Credit (LSE:BPCR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.bpcruk.com

BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.